Prognostic Usefulness of Basic Analytical Data in Chronic Obstructive Pulmonary Disease Exacerbation

Area of Science:

• Pulmonary Medicine
• Clinical Chemistry
• Biomarker Research

Background:

• Chronic Obstructive Pulmonary Disease (COPD) leads to significant morbidity, mortality, and healthcare costs.
• Identifying treatable traits in COPD exacerbations is crucial for optimizing patient management.
• Current research lacks robust data for systematic biomarker utilization in COPD care.

Purpose of the Study:

• To evaluate the short-term prognostic value of routine clinical and analytical parameters in patients experiencing COPD exacerbations.
• To identify key indicators of unfavorable outcomes following hospitalization for COPD exacerbations.

Main Methods:

• A multicenter prospective observational study was conducted from 2016 to 2018.
• Included patients were admitted for COPD exacerbation and provided informed consent.
• Unfavorable progression was defined as prolonged hospital stay, in-hospital mortality, or early readmission; 30-day mortality was also assessed.

Main Results:

• The study included 615 patients (mean age 73.9 years, 86.2% male).
• 58% of patients experienced unfavorable progression, with 6.7% mortality within 1 month post-discharge.
• Multivariate analysis identified elevated CRP/Albumin ratio (OR 1.008), urea (OR 1.01), and troponin T (OR 2.21) as predictors of unfavorable progression and 1-month mortality.

Conclusions:

• Elevated CRP/Albumin ratio, urea, and troponin T are significant prognostic indicators for poor short-term outcomes in COPD exacerbation patients.
• These findings suggest the role of cardiovascular comorbidity and systemic inflammation in exacerbation outcomes.
• These biomarkers can potentially be integrated into routine clinical practice for risk stratification.